Skip to content
  • Tuesday, 27 October 2026
  • 9:35 pm
  • Follow Us
Lab DB
  • Home
  • About Us
    • About Us
    • Affiliate Disclosure
    • Cookie Policy
    • Disclaimer
    • Privacy Policy
    • DMCA
    • Terms of Service
  • Contact Us
  • FAQ
  • Home
  • Breakthrough Cornell University Study Unveils Promising Path Toward Reversible, Nonhormonal Male Contraceptive
Stem Cell & Regenerative Medicine

Breakthrough Cornell University Study Unveils Promising Path Toward Reversible, Nonhormonal Male Contraceptive

Dwi Wanna Oct 23, 2026 0

Scientists at Cornell University have achieved a significant milestone in reproductive biology, moving closer to the long-sought goal of developing…

Read More
Pharmaceutical R&D

FDA Unveils Rare Disease Framework Initiative to Accelerate Novel Therapies and Streamline Drug Development

Teuku Ryan Oct 15, 2026 0

The United States Food and Drug Administration (FDA) has officially rolled out the Rare Disease Framework Initiative, a sweeping regulatory…

Read More
Stem Cell & Regenerative Medicine

Breakthrough Cornell University Study Unveils Promising Pathway Toward a Safe, Reversible Nonhormonal Male Contraceptive

Dwi Wanna Oct 12, 2026 0

Scientists at Cornell University have achieved a significant milestone in reproductive medicine, advancing closer to the long-sought goal of a…

Read More
Stem Cell & Regenerative Medicine

New Ludwig Cancer Research Study Unveils Promising Combination Therapy for Aggressive Acute Myelogenous Leukemia

Dwi Wanna Oct 6, 2026 0

Acute myelogenous leukemia remains one of the most formidable hematologic malignancies in modern oncology. Characterized by its rapid progression and…

Read More
Pharmaceutical R&D

Atossa Therapeutics Unveils Shareholder Cash Reward Plan Tied to Rare Disease Priority Review Vouchers

Teuku Ryan Oct 1, 2026 0

Atossa Therapeutics has officially established a groundbreaking financial framework designed to directly reward its shareholders with a substantial cash payout…

Read More
Pharmaceutical R&D

Ontario Bioscience Innovation Organization Capital Access Advisory Program Crosses C$1bn Milestone and Unveils 2026 Cohort

Teuku Ryan Sep 30, 2026 0

The landscape of Canadian health sciences received a monumental boost as the Ontario Bioscience Innovation Organization (OBIO) announced that enterprises…

Read More
Stem Cell & Regenerative Medicine

Breakthrough Cornell University Study Unveils Promising Path Toward Reversible Nonhormonal Male Contraception

Dwi Wanna Sep 26, 2026 0

Scientists at Cornell University have achieved a significant milestone in reproductive biology, moving closer to the long-sought goal of a…

Read More
Pharmaceutical R&D

Novo Unveils Post-Wegovy Growth Roadmap as Shares Slide Despite Ambitious 2030 Targets

Teuku Ryan Sep 22, 2026 0

The pharmaceutical landscape is undergoing a profound transformation, and Danish drugmaking giant Novo is aggressively positioning itself for a future…

Read More
Pharmaceutical R&D

Beijing Unveils Blueprint for Biomedical Dominance by 2030

Teuku Ryan Sep 21, 2026 0

The municipal government of Beijing has officially released a comprehensive strategic roadmap aimed at establishing the Chinese capital as a…

Read More
Stem Cell & Regenerative Medicine

Decoding the Explosive Origins of Chronic Myeloid Leukemia: A Landmark Study Unveils Unprecedented Cancer Cell Growth Rates Years Before Diagnosis

Dwi Wanna Sep 21, 2026 0

Recent findings published in the prestigious journal Nature have fundamentally shifted our scientific understanding of chronic myeloid leukemia (CML), a…

Read More

Posts pagination

1 2 … 7
Green Condiments on the Horizon: How Microalgae is Transforming Traditional Tomato Ketchup into a Functional SuperfoodImmunai’s Digital ‘Plumbing’ Keeps AstraZeneca Coming BackCERN Researchers Identify Potential Cracks in the Standard Model Following Unprecedented Observations at the Large Hadron ColliderCornell University Scientists Achieve Breakthrough in Developing Reversible and Nonhormonal Male Contraceptive Through Targeted Meiotic Interruption
The Most Favored Nation (MFN) Policy’s Unforeseen Ripple Effect: European Pharmaceutical Launches and Withdrawals PlummetJapan’s FY26 NHI Drug Price Revision: Deeper Dive into Mechanisms and Market ImpactEliquis Loss of Exclusivity: A Pharmaceutical Patent Cliff of Historic ProportionsMEDVi Under Scrutiny: AI-Powered Telehealth Startup Faces FDA Warnings, Deceptive Marketing Allegations, and Multiple Lawsuits Despite Meteoric Growth
Merck and Moderna’s cancer vaccine is customized for each patient’s tumorAn Unbiased Look at Google Gemini Omni: Features, Costs, and Market ComparisonESMO 2026: Sacituzumab Tirumotecan Sets New Survival Benchmark in Recurrent Endometrial CancerLight-Driven Magnetism Breakthrough Promises Ultrafast, High-Density Digital Data Storage
YOU MAY HAVE MISSED
Laboratory Automation & Robotics
Merck and Moderna’s cancer vaccine is customized for each patient’s tumor
Lana Keisha Oct 27, 2026
Data Science & Bioinformatics
An Unbiased Look at Google Gemini Omni: Features, Costs, and Market Comparison
Evan Lee Salim Oct 27, 2026
Pharmaceutical R&D
ESMO 2026: Sacituzumab Tirumotecan Sets New Survival Benchmark in Recurrent Endometrial Cancer
Teuku Ryan Oct 27, 2026
Advanced Materials Science
Light-Driven Magnetism Breakthrough Promises Ultrafast, High-Density Digital Data Storage
Nila Kartika Wati Oct 27, 2026

Copyright © 2026 | Powered by WordPress | News Gadgets by ThemeArile

  • Home
  • About Us
    • About Us
    • Affiliate Disclosure
    • Cookie Policy
    • Disclaimer
    • Privacy Policy
    • DMCA
    • Terms of Service
  • Contact Us
  • FAQ